Trial Profile
Efficacy of Abaloparatide-SC therapy in female patients with postmenopausal osteoporosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Jul 2017
Price :
$35
*
At a glance
- Drugs Abaloparatide (Primary)
- Indications Osteoporosis; Postmenopausal osteoporosis
- Focus Therapeutic Use
- 17 May 2016 New trial record
- 17 Apr 2016 Results presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases